LEUKEMIA, MYELOID CHRONIC

Clinical trials for LEUKEMIA, MYELOID CHRONIC explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA, MYELOID CHRONIC trials appear

Sign up with your email to follow new studies for LEUKEMIA, MYELOID CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Completed 1

New combo therapy shows promise for Hard-to-Treat CML

Disease control Completed

This study looked at adding a new drug, asciminib, to the standard treatment imatinib for people with chronic myeloid leukemia (CML) who hadn't reached very low levels of cancer cells. 104 adults who had been on imatinib for at least a year were randomly assigned to add asciminib…

Matched conditions: LEUKEMIA, MYELOID CHRONIC

Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated May 26, 2026 07:26 UTC

LEUKEMIA, MYELOID CHRONIC

Get alerted when new LEUKEMIA, MYELOID CHRONIC trials appear

New combo therapy shows promise for Hard-to-Treat CML